By analyzing epigenomic and gene expression changes that occur in Alzheimer’s disease, researchers identify cellular pathways that could become new drug targets.
David Orenstein | The Picower Institute for Learning and Memory
Neurons stochastically generated up to eight different versions of a protein-regulating neurotransmitter release, which could vary how they communicate with other cells.
Maura R. O'Connor | Department of Brain and Cognitive Sciences
Department of Brain and Cognitive Sciences faculty members Ev Fedorenko, Ted Gibson, and Roger Levy believe they can answer a fundamental question: What is the purpose of language?
David Orenstein | The Picower Institute for Learning and Memory
A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, reducing disease pathology, preserving neurons, and improving cognition in preclinical tests.
David Orenstein | The Picower Institute for Learning and Memory
Researchers compared a pair of superficially similar motor neurons in fruit flies to examine how their differing use of the same genome produced distinctions in form and function.
David Orenstein | The Picower Institute for Learning and Memory
Three graduate students forged a path to the same Picower Institute lab through participating in the MIT Summer Research Program in Biology and Neuroscience.